Corrigendum to "Identification of a mesothelioma phenotype" (DOI:10.1016/j.rmed.2006.06.028);Identification of a mesothelioma phenotype

Respiratory Medicine

Volumn 101, Issue 3, 2007, Pages 503-509

  Ohar, Jill A ^a   Ampleford, Elizabeth J ^a   Howard, Suzanne E ^a   Sterling, David A ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Asbestos; Mesothelioma; Occupational disease

Indexed keywords

ASBESTOS;

ADULT; AGED; ARTICLE; ASBESTOSIS; BRONCHUS CANCER; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MESOTHELIOMA; OCCUPATIONAL EXPOSURE; PERITONEUM TUMOR; PHENOTYPE; PLEURA METASTASIS; PLEURA THICKENING; PLEURAL FIBROSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SECOND CANCER; SEX DIFFERENCE; SURVIVAL TIME; THORAX TUMOR; TUMOR LOCALIZATION;

EID: 33846651923     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.10.020     Document Type: Erratum

References (41)

1. Bonomo L., Feragalli B., Sacco R., Merlino B., and Storto M.L. Malignant pleural disease. Eur J Radiol 34 2 (2000) 98-118
2. Neragi-Miandoab S. Multimodality approach in management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 29 1 (2006) 14-19
3. Robinson B.W., Musk A.W., and Lake R.A. Malignant mesothelioma. Lancet 366 9483 (2005) 397-408
4. Neragi-Miandoab S. Eur J Cardiothorac Surg 29 1 (2006) 14-19 Epub December 15, 2005
5. Bertazzi P.A. Descriptive epidemiology of malignant mesothelioma. Med Lav 96 4 (2005) 287-303
6. Paul S., Neragi-Miandoab S., and Jaklitsch M.T. Preoperative assessment and therapeutic options for patients with malignant pleural mesothelioma. Thorac Surg Clin 14 4 (2004) 505-516
7. Robinson B.W., and Lake R.A. Advances in malignant mesothelioma. N Engl J Med 353 15 (2005) 1591-1603
8. Pistolesi M., and Rusthoven J. Malignant pleural mesothelioma: update, current management, and newer therapeutic strategies. Chest 126 4 (2004) 1318-1329
9. Roushdy-Hammady I., Siegel J., Emri S., Testa J.R., and Carbone M. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet 357 9254 (2001) 444-445
10. Emri S., and Demir A.U. Malignant pleural mesothelioma in Turkey, 2000-2002. Lung Cancer 45 Suppl 1 (2004) S17-S20
11. Giuseppe U.D., and Comba P. Malignant pleural mesothelioma. Chest 125 (2004) 1604-1607
12. Musti M., Cavone D., Aalto Y., Scattone A., Serio G., and Knuutila S. A cluster of familial malignant mesothelioma with del(9p) as the sole chromosomal anomaly. Cancer Genet Cytogenet 138 1 (2002) 73-76
13. Ascoli V., Aalto Y., Carnovale-Scalzo C., et al. DNA copy number changes in familial malignant mesothelioma. Cancer Genet Cytogenet 127 1 (2001) 80-82
14. Meyers D.A., Postma D.S., Stine O.C., et al. Genome screen for asthma and bronchial hyperresponsiveness: interactions with passive smoke exposure. J Allergy Clin Immunol 115 6 (2005) 1169-1175
15. Bleecker E.R., Postma D.S., and Meyers D.A. Genetic susceptibility to asthma in a changing environment. Ciba Found Symp 206 (1997) 90-99 discussion 99-105,106-110
16. Metintas M., Metintat S., Ucgun I., Gibbs A.R., Harmanci E., Alatas F., et al. Prognostic factors in diffuse malignant pleural mesothelioma: effects of pretreatment clinical and laboratory characteristics. Respir Med 95 (2001) 829-835
17. American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med 170 6 (2004) 691-715
18. Ohar J., Sterling D.A., Bleecker E.R., and Donohue J. Changing patterns in asbestos-induced lung disease. Chest 125 (2004) 744-753
19. ILO international classification of radiographs of pneumoconioses, 1980 (No. 22 revised). Occupational safety and health series. Geneva, Switzerland: International Labour Office. 1980.
20. Huncharek M., Capotorto J.V., and Muscat J. Domestic asbestos exposure, lung fibre burden, and pleural mesothelioma in a housewife. Br J Ind Med 46 5 (1989) 354-355
21. Kilburn K.H., Lilis R., Anderson H.A., et al. Asbestos disease in family contacts of shipyard workers. Am J Public Health 75 6 (1985) 615-617
22. Newhouse M.L., and Thompson H. Mesothelioma of pleura and peritoneum following exposure to asbestos in the London area. Br J Ind Med 22 4 (1965) 261-269
23. Anderson H.A., Lilis R., Daum S.M., and Selikoff I.J. Asbestosis among household contacts of asbestos factory workers. Ann NY Acad Sci 330 (1979) 387-399
24. Miller A. Mesothelioma in household members of asbestos-exposed workers: 32 United States cases since 1990. Am J Ind Med 47 5 (2005) 458-462
25. Metintas M., Ozdemir N., Hillerdal G., Ucgun I., Metintas S., Baykul C., et al. Environmental asbestos exposure and malignant pleural mesothelioma. Respir Med 93 (1999) 349-355
26. Hirvonen A., Pelin K., Tammilehto L., Karjalainen A., Mattson K., and Linnainmaa K. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. Cancer Res 55 (1995) 2981-2983
27. Hirvonen A., Saarikoski S.T., Linnainmaa K., Koskinen K., Husgafvel-Pursiainen K., Mattson K., et al. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J Natl Cancer Inst 88 24 (1996) 1853-1856
28. Neri M., Filiberti R., Taioli E., Garte S., Paracchini V., Bolognesi C., et al. Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure. Mutat Res 592 1-2 (2005) 36-44
29. Stucker I., Boffetta P., Antilla S., Benhamou S., Hirvonen A., London S., et al. Lack of interaction between asbestos exposure and glutathione S-transferase M1 and T1 genotypes in lung carcinogenesis. Cancer Epidemiol Biomakers Prev 10 (2001) 1253-1258
30. Berry G., and Wagner J.C. Effect of age at inoculation of asbestos on occurrence of mesotheliomas in rats. Int J Cancer 17 (1976) 477
31. Peto J., Seidman H., and Selikoff I.J. Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer 45 (1982) 124-135
32. Becklake M.R., Toyota B., Stewart M., Hanson R., and Hanley J. Lung structure as a risk factor in adverse pulmonary responses to asbestos exposure. A case-referent study in Quebec chrysotile miners and millers. Am Rev Respir Dis 128 3 (1983) 385-388
33. Smith D.D. Women and mesothelioma. Chest 122 (2002) 1885-1886
34. Pass H.L., Vogelzang N., Hahn S., and Carbone M. Malignant pleural mesothelioma. Curr Probl Cancer 28 3 (2004) 93-174
35. British Thoracic Society Standards of Care Committee. Statement on malignant mesothelioma in the United Kingdom. Thorax 56 4 (2001) 250-265
36. Bianchi C., Giarelli L., Grandi G., Brollo A., Ramani L., and Zuch C. Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev 6 (1997) 162-166
37. Bianchi C., Brollo A., Ramani L., Bianchi T., and Giarelli L. Asbestos exposure in malignant mesothelioma of the pleura: a survey of 557 cases. Ind Health 39 2 (2001) 161-167
38. Muscat J.E., and Wynder E.L. Cigarette smoking, asbestos exposure, and malignant mesothelioma. Cancer Res 51 9 (1991) 2263-2267
39. Gottschall E.B. Occupational and environmental thoracic malignancies. J Thorac Imag 17 3 (2002) 189-197
40. Vianna N.J., and Polan A.K. Non-occupational exposure to asbestos and malignant mesothelioma in females. Lancet 1 8073 (1978) 1061-1063
41. Heineman E.F., Bernstein L., Stark A.D., and Spirtas R. Mesothelioma, asbestos, and reported history of cancer in first-degree relatives. Cancer 77 3 (1996) 549-554